Pharma Pulse 11/18/24: Bringing the Human Story to AI, Addressing Payer Coverage Challenges & more

Noam Solomon: Bringing the Human Story to AI

A look at one biotech’s mission to map the immune system using artificial intelligence—and how its growth as a Big Pharma partner could help unlock the potential of next-generation cancer treatments.

Addressing Payer Coverage Challenges

Panelists discuss how they navigate challenges with payer coverage for quadruplet regimens in multiple myeloma treatment, including strategies they employ to address insurance denials or restrictions, such as providing clinical justification, leveraging recent trial data, and collaborating with financial assistance programs to ensure patients can access optimal therapy despite potential coverage difficulties.

Elon Musk Adds Microsoft to Suit Against OpenAI

In a new legal filing, the Tesla chief executive accuses the A.I. start-up of undermining antitrust law.

Perspectum Awarded New FDA Grant to Evaluate Biomarker for Rare Disease Drug Development

Perspectum announced that it has been awarded a 2024 U.S. Food and Drug Administration Drug Development Tool (DDT) Research Grant to evaluate a novel biomarker aimed at addressing the unmet needs of patients with rare diseases. This award highlights Perspectum’s steadfast commitment to supporting targeted therapies that improve patient care and quality of life.

Timothy Marsh on LinkedIn

Neat, looking forward to the coming episodes!

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs